Abstract: Antimicrobial and anticancer peptides engineered using Gaegurin 5 isolated from Korean frog (Rana rugosa), which have a smaller structure compared with previously known Gaegurin peptides and show potent antimicrobial and anticancer activity. Specifically, the antimicrobial and anticancer peptides synthesized from the shortest length of Gaegurin 5, show potent antimicrobial activity against gram positive and negative strains, good safety with very low hemolytic activity and favorable advantages such as drug absorption and drug transportation due to its advantageous structural property, which can be useful as a potent antimicrobial or anticancer agent.
Type:
Grant
Filed:
May 14, 2007
Date of Patent:
December 13, 2011
Assignee:
Promeditech, Inc.
Inventors:
Bong Jin Lee, Min Duk Seo, Su Jin Kang, Hyun Jung Kim
Abstract: The present invention is related to antimicrobial and anticancer peptide engineering using Gaegurin 5 isolated from Korean frog (Rana rugosa), which have smaller structure compared with previously known Gaegurin peptide and shows potent antimicrobial and anticancer activity. Specifically, the antimicrobial and anticancer peptide of the present invention synthesized from the shortest length of Gaegurin 5, show potent antimicrobial activity against gram positive and negative strains, good safety with very low hemolytic activity and favorable advantages such as drug absorption and drug transportation due to its advantageous structural property, which can be useful as a potent antimicrobial or anticancer agent.
Type:
Application
Filed:
May 14, 2007
Publication date:
April 29, 2010
Applicant:
PROMEDITECH, INC
Inventors:
Bong Jin LEE, Min Duk SEO, Su Jin KANG, Hyun Jung KIM